Myeloma Trial, Recruiting NCT03858205 Sponsor: University of Southern California Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT03858205
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with multiple myeloma (a type of blood cancer affecting bone marrow), confirmed by a tissue sample test.
  • You have a painful bone lesion (a specific affected area called the "index lesion") that can be seen on a scan or X-ray.
  • You may have had any number of previous chemotherapy or immunotherapy treatments before joining.
  • You are reasonably active and able to care for yourself, with only mild limitations in daily activities (confirm with trial site).
  • You have a pain score of 2 or higher on a standard pain questionnaire called the Brief Pain Inventory.
  • You are able to understand the study and are willing to sign a consent form.

Who may not be able to join:

  • The specific bone lesion being studied has already been treated with radiation therapy or surgery to relieve pain.
  • There is a broken bone, a bone at risk of breaking, or planned surgery to fix the bone at the specific lesion being studied.
  • There are signs that the specific lesion is pressing on the spinal cord or nearby nerves, or the lesion is located at the base of the skull or in the eye socket area.
  • You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Adam Garsa, MD, University of Southern California

Phone: 323-865-0371

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 March 2019
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov